Company · Clermont-Ferrand, Cedex 2, France
Laboratoires Théa
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 5
- 5 authorized now
- Natural health products
- 1
- 1 active licences
- Medical device licences
- 15
- 6 active
- Notices of Compliance
- 11
Drug products
Authorized products first.
Natural health products
Active licences first, newest first.
| Name | NPN | Status | Licensed |
|---|---|---|---|
| Nutrof TotalLicensed Jul 2022 | 80120226 | Active |
Medical device licences
Active licences first, newest first.
| Name | Licence | Status | First licensed |
|---|---|---|---|
| THEALOZ TOTALFirst licensed Jul 2025 | 113728 | Issued (active) · Class 2 | |
| THEALOZ GELFirst licensed Jun 2025 | 113485 | Issued (active) · Class 2 | |
| THEAHYABAKFirst licensed Nov 2024 | 112159 | Issued (active) · Class 2 | |
| BLEPHACLEANFirst licensed Dec 2021 | 107085 | Issued (active) · Class 2 | |
| THEALOZ DUO GELFirst licensed Mar 2019 | 102505 | Issued (active) · Class 2 | |
| THEALOZ DUOFirst licensed Jan 2014 | 92551 | Issued (active) · Class 2 | |
| BLEPHASTEAMFirst licensed Aug 2014 | 93685 | Discontinued at renewal · Class 2 | |
| THEALOZFirst licensed May 2013 | 91239 | Discontinued at renewal · Class 2 | |
| HYABAKFirst licensed May 2013 | 91240 | Cancelled · Class 2 | |
| LARMABAK, 0.9% NACLFirst licensed May 2012 | 88945 | Discontinued at renewal · Class 2 | |
| SICCAFLUID CARBOMER 974P, 0.25%First licensed May 2012 | 88946 | Discontinued at renewal · Class 2 | |
| GEL-LARMES CARBOMER 974P, GELFirst licensed May 2012 | 88947 | Discontinued at renewal · Class 2 | |
| GEL-LARMES CARBOMER 974P, GELFirst licensed Jan 2003 | 61715 | Discontinued at renewal · Class 2 | |
| LARMABAK , 0.9% NACLFirst licensed Jan 2003 | 61716 | Discontinued at renewal · Class 2 | |
| SICCAFLUID CARBOMER 974P, 0.25%First licensed Jan 2003 | 61717 | Discontinued at renewal · Class 2 |
Notices of Compliance
Newest first.
- ZOLYMBUSSeptember 25, 2026 · NOC 38374 · New Drug Submission (NDS)
- DUOKOPTSeptember 10, 2024 · NOC 33994 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ZADITORJuly 8, 2024 · NOC 33595 · Supplement to a New Drug Submission (SNDS)
- EYEZIRGANJune 5, 2024 · NOC 33395 · Supplement to a New Drug Submission (SNDS)
- DUOKOPTOctober 12, 2023 · NOC 31848 · Supplement to an Abbreviated New Drug Submission (SANDS)
- EYEZIRGANSeptember 8, 2022 · NOC 28910 · New Drug Submission (NDS)
- DUOKOPTApril 29, 2022 · NOC 28077 · Abbreviated New Drug Submission (ANDS)
- MONOPROSTApril 15, 2020 · NOC 23454 · Supplement to a New Drug Submission (SNDS)
- MONOPROSTJuly 7, 2016 · NOC 18236 · New Drug Submission (NDS)
- ZADITORMarch 24, 2016 · NOC 17931 · Supplement to a New Drug Submission (SNDS)
- ZADITORMarch 30, 2012 · NOC 13177 · New Drug Submission (NDS)